Published in J Clin Hypertens (Greenwich) on January 30, 2003
Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study. J Hypertens (2009) 1.04
Hepatic steatosis in overweight/obese females: new screening method for those at risk. World J Gastroenterol (2009) 0.84
What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease? BMC Med (2015) 0.78
Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative. Clinicoecon Outcomes Res (2012) 0.75
It's Complicated: Marital Ambivalence on Ambulatory Blood Pressure and Daily Interpersonal Functioning. Ann Behav Med (2015) 0.75
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation (2004) 7.77
Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med (2010) 7.39
Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation (2003) 4.52
Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med (2007) 3.30
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med (2006) 3.05
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J (2005) 2.74
Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med (2003) 2.59
Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview. Hypertension (2007) 2.43
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (2012) 2.42
Hypertension management: results of a new national survey for the hypertension education foundation: Harris interactive. J Clin Hypertens (Greenwich) (2007) 2.28
Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2002) 2.13
Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ (2010) 1.72
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis (2005) 1.65
Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study. J Hypertens (2002) 1.51
Walking speed predicts health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev (2005) 1.48
Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs. Am J Geriatr Cardiol (2007) 1.48
The burden of narcolepsy with cataplexy: how disease history and clinical features influence socio-economic outcomes. Sleep Med (2012) 1.46
Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. J Hypertens (2011) 1.43
Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension (2005) 1.41
Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension (2004) 1.40
Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry (2004) 1.39
Arterial stiffness and hypertension: a two-way street? Hypertension (2005) 1.37
Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol (2008) 1.31
Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension (2005) 1.31
Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J (2003) 1.26
Isolated systolic hypertension in the young: a need for clarity. J Hypertens (2013) 1.16
The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord (2002) 1.16
Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. J Diabetes Complications (2012) 1.14
Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med (2004) 1.10
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. Eur Heart J (2009) 1.09
Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol (2003) 1.09
Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension (2005) 1.07
The impact of cardiovascular risk factors on aortic stiffness and wave reflections depends on age: the Anglo-Cardiff Collaborative Trial (ACCT III). Hypertension (2010) 1.07
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J (2004) 1.07
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. Eur Psychiatry (2007) 1.05
Body mass index and hypertension hemodynamic subtypes in the adult US population. Arch Intern Med (2009) 1.04
An update on biomarkers of heart failure in hypertensive patients. J Hypertens (2012) 1.04
Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int (2002) 1.03
Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol (2005) 1.01
Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination. Arch Clin Neuropsychol (2004) 1.01
Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension (2006) 1.00
Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. J Magn Reson Imaging (2012) 0.99
Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study. Curr Ther Res Clin Exp (2005) 0.99
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging (2012) 0.98
Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes (2012) 0.98
The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry (2008) 0.98
Cardiovascular comorbidities and blood pressure control in stroke survivors. J Hypertens (2009) 0.98
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy. Eur J Clin Pharmacol (2008) 0.98
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study. Pharmacoepidemiol Drug Saf (2009) 0.98
beta-Blockers in hypertension-the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension. Am J Hypertens (2003) 0.98
The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail (2004) 0.96
Geographic variation in health care utilization and outcomes in veterans with acute myocardial infarction. J Gen Intern Med (2002) 0.95
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J Med Econ (2011) 0.94
Blood pressure and pulse wave velocity as metrics for evaluating pathologic ageing of the cardiovascular system. Blood Press (2013) 0.94
VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purif (2011) 0.92
Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. FASEB J (2006) 0.92
Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension. J Clin Hypertens (Greenwich) (2006) 0.91
Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group. Am J Hypertens (2012) 0.90
The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther (2003) 0.90
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag (2007) 0.90
Age-dependent associations between blood pressure and coronary artery calcification in asymptomatic adults. J Hypertens (2004) 0.89
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. Diabetes Res Clin Pract (2004) 0.89
Weight gain and new onset diabetes associated with olanzapine and risperidone. J Gen Intern Med (2004) 0.88
Global cardiovascular disease risk assessment in United States adults with diabetes. Diab Vasc Dis Res (2012) 0.88
Arterial stiffness: reflections on the arterial pulse. Eur Heart J (2006) 0.88
Blood pressure lowering and life expectancy based on a Markov model of cardiovascular events. Hypertension (2003) 0.87
Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Press Suppl (2003) 0.87
Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens (2004) 0.87
Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status. Diab Vasc Dis Res (2013) 0.87
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging (2013) 0.87
Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. J Clin Hypertens (Greenwich) (2007) 0.86
Non-pharmacological control of plasma cholesterol levels. Nutr Metab Cardiovasc Dis (2008) 0.86
Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? Blood Purif (2009) 0.86
Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study. Clin Cases Miner Bone Metab (2013) 0.86
Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up. BMC Med (2011) 0.85
Association between urinary albumin excretion and both central and peripheral blood pressure in subjects with insulin resistance. J Hypertens (2013) 0.85
The clinically meaningful change in physical performance scores in an elderly cohort. Aging Clin Exp Res (2007) 0.85
Regional variation in health care utilization and outcomes in ischemic stroke. J Stroke Cerebrovasc Dis (2007) 0.85
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer (2014) 0.85
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. J Clin Endocrinol Metab (2015) 0.85
The nonpharmacologic treatment of hypertension: how effective is it? An update. J Clin Hypertens (Greenwich) (2007) 0.84
[Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project]. G Ital Cardiol (Rome) (2007) 0.84
Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension. J Clin Hypertens (Greenwich) (2007) 0.84
Long-term effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: the Brisighella Heart Study. J Womens Health (Larchmt) (2010) 0.83
The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor kidney transplantation. J Med Econ (2012) 0.83
Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects. J Am Diet Assoc (2002) 0.83
Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Clin Ther (2009) 0.82
The efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk. J Clin Hypertens (Greenwich) (2007) 0.82